Literature DB >> 1361401

The local intracoronary administration of methylene blue prevents the pronounced antiarrhythmic effect of ischaemic preconditioning.

A Vegh1, J G Papp, L Szekeres, J Parratt.   

Abstract

Short periods of coronary artery occlusion (2 x 5 min) markedly reduce the severity of arrhythmias and the changes in ST-segment elevation and in the degree of inhomogeneity of conduction during a subsequent 25 min occlusion of the left anterior descending coronary artery in anaesthetized dogs. These changes were completely reversed if methylene blue (5 mg min-1) was infused into a side branch of the coronary artery throughout both the preconditioning and prolonged occlusions. These results suggest that the pronounced antiarrhythmic effects of preconditioning result from activation of guanylyl cyclase and result in increased levels of guanosine 3':5'-cyclic monophosphate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1361401      PMCID: PMC1907949          DOI: 10.1111/j.1476-5381.1992.tb13384.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

Review 1.  Endothelium, endocardium, and cardiac contraction.

Authors:  A H Henderson; M J Lewis; A M Shah; J A Smith
Journal:  Cardiovasc Res       Date:  1992-04       Impact factor: 10.787

Review 2.  Ischaemic preconditioning: from mechanisms to exploitation.

Authors:  D M Walker; D M Yellon
Journal:  Cardiovasc Res       Date:  1992-08       Impact factor: 10.787

3.  Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.

Authors:  G S Liu; J Thornton; D M Van Winkle; A W Stanley; R A Olsson; J M Downey
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

4.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta.

Authors:  W Martin; G M Villani; D Jothianandan; R F Furchgott
Journal:  J Pharmacol Exp Ther       Date:  1985-03       Impact factor: 4.030

5.  Protective effects of preconditioning of the ischaemic myocardium involve cyclo-oxygenase products.

Authors:  A Vegh; L Szekeres; J R Parratt
Journal:  Cardiovasc Res       Date:  1990-12       Impact factor: 10.787

6.  Effect of carbachol and cyclic GMP on susceptibility to ventricular fibrillation.

Authors:  G E Billman
Journal:  FASEB J       Date:  1990-04-01       Impact factor: 5.191

7.  Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs.

Authors:  A Vegh; L Szekeres; J R Parratt
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

8.  Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats.

Authors:  A Vegh; S Komori; L Szekeres; J R Parratt
Journal:  Cardiovasc Res       Date:  1992-05       Impact factor: 10.787

  8 in total
  16 in total

1.  Anti-arrhythmic effect of diosgenin in reperfusion-induced myocardial injury in a rat model: activation of nitric oxide system and mitochondrial KATP channel.

Authors:  Reza Badalzadeh; Bahman Yousefi; Maryam Majidinia; Hadi Ebrahimi
Journal:  J Physiol Sci       Date:  2014-08-24       Impact factor: 2.781

2.  A pharmacological analysis of the possible role of vasoactive mediators in compensatory coronary blood flow.

Authors:  James R Parratt; Agnes Végh
Journal:  Exp Clin Cardiol       Date:  2008

Review 3.  Ischaemic preconditioning of myocardium: a new paradigm for clinical cardioprotection?

Authors:  G F Baxter; D M Yellon
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

4.  Time course analysis of cardiac pacing-induced gene expression changes in the canine heart.

Authors:  Mária Kovács; Márton Gönczi; Edina Kovács; Agnes Végh
Journal:  Mol Cell Biochem       Date:  2012-09-27       Impact factor: 3.396

5.  Activation of cardiac muscarinic receptor and ischemic preconditioning effects in in situ rat heart.

Authors:  F Yamaguchi; Y Nasa; K Yabe; S Ohba; Y Hashizume; H Ohaku; K Furuhama; S Takeo
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

6.  Modulation of gap junctions by nitric oxide contributes to the anti-arrhythmic effect of sodium nitroprusside?

Authors:  Márton Gönczi; Rita Papp; Mária Kovács; György Seprényi; Agnes Végh
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

7.  Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs.

Authors:  A Vegh; J G Papp; L Szekeres; J R Parratt
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

Review 8.  Effects of brief ischemia and reperfusion on the myocardium and the role of nitric oxide.

Authors:  Christopher S R Baker; Sanjay Kumar; Ornella E Rimoldi
Journal:  Heart Fail Rev       Date:  2003-04       Impact factor: 4.214

9.  A common mechanism in the protective effects of preconditioning, cardiac pacing and physical exercise against ischemia and reperfusion-induced arrhythmias.

Authors:  Agnes Végh; James R Parratt
Journal:  Exp Clin Cardiol       Date:  2005

10.  Peroxynitrite decreases arrhythmias induced by ischaemia reperfusion in anaesthetized dogs, without involving mitochondrial KATP channels.

Authors:  A Kiss; L Juhász; I Huliák; A Végh
Journal:  Br J Pharmacol       Date:  2008-09-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.